Breaking News, Promotions & Moves

Kincell Bio Appoints Mark R. Bamforth as CEO

Bamforth brings decades of industry experience to the role.

Author Image

By: Charlie Sternberg

Associate Editor

Mark R. Bamforth.

Kincell Bio, a cell therapy development and manufacturing organization (CDMO), has appointed Mark R. Bamforth as Chief Executive Officer (CEO), effective immediately. Bamforth, who has served as Chair of the Board since May 2024, will play a pivotal part in advancing Kincell Bio’s mission to support innovators in the rapidly growing cell therapy sector. This news follows the announcement in November that Kincell had appointed Dr. Stewart McNaull as Chief Commercial Officer. Experience ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters